Meeting Highlights Information Registration Visa Letter Application Programme Overview Exhibition Virtual Exhibition Hotels Exhibition Virtual Exhibition Satellite Programme


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Dry eye syndrome in children with allergy

Poster Details


First Author: Y.Hulobova UKRAINE

Co Author(s): N. Malachkova                    

Abstract Details

Purpose:

The aim of our study was to study the prevalence of syndrome among pediatric patients suffering from various manifestations of allergy (allergic dermatitis, pollinosis, bronchial asthma allergic origin).

Setting:

VPNMMU (Vinnitsa Regional Children's Hospital)

Methods:

We examined 102 children aged 6 to 17 years with the following pathologies: polynosis, allergic dermatitis, bronchial asthma of allergic origin, refractive pathologies. The examination plan included: questionnaire survey, slit lamp examination with fluorescein staining, Schirmer test, Norn test.

Results:

Of all patients with clinical manifestations of dry eye syndrome, only 13.3% reported complaints of dryness and foreign body sensation. Only 20% of patients had objective changes from the meibomian glands, conjunctiva and cornea. In 23% of patients with a history of allergies, without visible symptoms of exacerbation at the time of examination, signs of dry eye syndrome are noted. However, this rate reaches 41.7% during the clinical manifestation of allergy. It should be noted that among children with refractive pathologies, signs of dry eye syndrome were found in 4.4% and one third of them had a defined allergic history.

Conclusions:

Dry eye syndrome in childhood is a fairly common problem. Our findings indicate that children with a severe allergic history (even without manifestations of allergic conjunctivitis) should be examined by an ophthalmologist for signs of a dry eye. Our examination was limited to children who went to the hospital. However, the diagnosis of dry eye syndrome in ophthalmic patients suggests that the disease is symptomatic in the general population and requires safe and long-term treatment.

Financial Disclosure:

None

Back to Poster listing